Summary
Secretion of tritium-labeled digoxin was studied in rats using noneverted gut sacs, in ligated and perfused intestinal preparations in bile duct ligated rats, and by measuring 4 day fecal excretion of total radioactivity in bile duct ligated rats. Serosal to mucosal transfer was proportional to substrate concentration in vitro. In ligated intestinal loops radioactivity was concentrated in the lumen relative to serum. In perfused intestinal preparations the fraction of dose increased with time and was similar over a 100-fold range of doses. Bile duct ligated rats excreted 13.4±5.8 (S.D.)% of parenterally administered label in 4 day stool collections. Bile duct ligated rats treated with p.o. activated charcoal excreted significantly more radioactivity (33.4±7.9%). The results suggest that net nonbiliary intestinal secretion of digoxin and metabolites can be augmented by intraluminal binding. A role for this phenomenon in accounting for some effects of diseases and drug interactions is suggested.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brown, D. D., Juhl, R. P.: Decreased biovailability of diogoxin due to antacids and kaolin-pectin. N. Engl. J. Med. 295, 1034–1037 (1976)
Brown, D. D., Juhl, R. P., Warner, A. L.: Decreased bioavailability of digoxin due to hypocholesterolemic interventions. Circulation 58, 164–172 (1978)
Caldwell, J. H., Greenberger, N. J.: Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication. J. Clin. Invest. 50, 2626–2637 (1971)
Caldwell, J. H., Cline, C. T.: Biliary excretion of digoxin in man. Clin. Pharmacol. Ther. 19, 410–415 (1976)
Caldwell, J. H., Martin, J. F., Dutta, S., Greenberger, N. J.: Intestinal absorption of digoxin-3H in the rat. Am. J. Physiol. 217, 1747–1751 (1969)
Damm, K.-H., Woermann, C.: The effect of probenecid on the in vitro absorption of cardiac glycosides. Eur. J. Pharmacol. 28, 157–163 (1974)
Doherty, J. E., Flanigan, W. J., Perkins, W. H.: Tritiated digoxin excretion of patients following renal transplantation. Circulation 37, 865–869 (1968)
Doherty, J. E., Flanigan, W. J., Murphy, M. L., Bulloch, R. T., Dalrymple, G. L., Beard, D. W., Perkins, W. H.: Tritiated digoxin. XIV. Enterohepatic circulation, absorption, and excretion studies in human volunteers. Circulation 42, 867–873 (1970)
Forth, W., Furukawa, E., Rummel, W.: Intestinale Resorption von Herzglykosiden in vitro und in vivo. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 262, 53–72 (1969)
Haass, A., Lüllman, H., Peters, T.: Absorption rates of some cardiac glycosides and portal blood flow. Eur. J. Pharmacol 19, 366–370 (1972)
Hall, W. H., Doherty, J. E.: Tritiated digoxin. XXII. Absorption and excretion in malabsorption syndromes. Am. J. Med. 56, 437–442 (1974)
Harrison, L. I., Gibaldi, M.: Physiologically based pharmacokinetic model for digoxin distribution and elimination in the rat. J. Pharmacol. Sci. 66, 1138–1142 (1977)
Harrison, C. H., Brandenburg, R. O., Ongley, P. A., Orvis, A. L., Owen, C. A.: The distribution and excretion of tritiated substances in experimental animals following the administration of digoxin-3H. J. Lab. Clin. Med. 67, 764–777 (1966)
Heizer, W. D., Smith, T. W., Goldfinger, S. E.: Absorption of digoxin in patients with malabsorption syndromes. J. Engl. J. Med. 285, 257–259 (1971)
Kolibash, A. J., Kramer, W. G., Reuning, R. H., Caldwell, J. H.: Marked decline in serum digoxin concentrations during an episode of severe diarrhea. Am. Heart J. 94, 806–807 (1977)
Koup, J. R., Greenblatt, D. J., Jusko, W. J., Smith, T. W., Koch-Weser, J.: Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses. J. Pharmacokinet. Biopharm. 3, 181–192 (1975)
Lauterbach, F.: Resorption und Sekretion von Arzneistoffen durch die Mukosaepithelien des Gastrointestinaltraktes. Arzneim. Forsch. 25, 479–488 (1975)
Marcus, F. I., Kapadia, G. G.: The metabolism of tritiated digoxin in cirrhotic patients. Gastroenterology 47, 517–524 (1964)
Marcus, F. I., Peterson, A., Salel, A., Scully, J., Kapadia, G. G.: The metabolism of tritiated digoxin in renal insufficiency in dogs and man. J. Pharmacol. Exp. Ther. 152, 372–382 (1966)
Neuvonen, P. J., Elfving, S. M., Elonen, E.: Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man. Eur. J. Clin. Pharmacol. 13, 213–218 (1978)
Ochs, H. R., Greenblatt, D. J., Bodem, G., Harmatz, J. S.: Doseindependent pharmacokinetics of digoxin in humans. Am. Heart J. 96, 507–511 (1978)
Selden, R., Margolies, M. N., Smith, T. W.: Renal and gastrointestinal excretion of ouabain in dog and man. J. Pharmacol. Exp. Ther. 188, 615–623 (1974)
Smiley, J. W., March, N. M., DelGuercio, E. T.: Hemoperfusion in the management of digoxin toxicity. J. Am. Med. Assoc. 240, 2736–2737 (1978)
Zajtchuk, R., Corby, D. G., Miller, J. G., O'Barr, T. P.: Treatment of digoxin toxicity with activated charcoal. Am. J. Cardiol. 35, 178 (1975) (Abstract)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Caldwell, J.H., Caldwell, P.B., Murphy, J.W. et al. Intestinal secretion of digoxin in the rat. Naunyn-Schmiedeberg's Arch. Pharmacol. 312, 271–275 (1980). https://doi.org/10.1007/BF00499157
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00499157